Skip to main content

DYSPORT (Ipsen Pty Ltd)

Product name
DYSPORT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
149 working days (255)
Active ingredients
Clostridium botulinum type a toxin haemagglutinin complex
Registration type
EOI
Indication
DYSPORT (containing clostridium botulinum type a toxin haemagglutinin complex) is now also indicated for the treatment of moderate to severe glabellar lines and , or lateral canthal lines (crow's feet) in adults.

Help us improve the Therapeutic Goods Administration site